Cargando…

Comparison of SARS‐CoV‐2 neutralizing antibody testing of convalescent plasma donations in the Netherlands and England: A pilot study

Detalles Bibliográficos
Autores principales:	Harvala, Heli, Gopal, Robin, Patel, Monika, Zambon, Maria, Roberts, David, Lamikanra, Abigail, Ploeg, Rutger, Hoogerwerf, Marieke, Zaaijer, Hans, Hogema, Boris, Reusken, Chantal, van der Schoot, Ellen, Reimerink, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637097/ https://www.ncbi.nlm.nih.gov/pubmed/34888419 http://dx.doi.org/10.1002/hsr2.439

Ejemplares similares

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
por: Wouters, Elise, et al.
Publicado: (2020)

Comparability of six different immunoassays measuring SARS‐CoV‐2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction
por: Lamikanra, Abigail, et al.
Publicado: (2021)

Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
por: Steenhuis, Maurice, et al.
Publicado: (2021)

Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Strain Variation on Virus Neutralization Titers: Therapeutic Use of Convalescent Plasma
por: Nguyen, Dung, et al.
Publicado: (2021)

Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands
por: Slot, Ed, et al.
Publicado: (2020)

Past and present of hepatitis E in the Netherlands
por: Hogema, Boris M, et al.
Publicado: (2014)

Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England
por: Williams, Sarah, et al.
Publicado: (2022)

The Relationship Between SARS-CoV-2 Neutralizing Antibody Titers and Avidity in Plasma Collected From Convalescent Nonvaccinated and Vaccinated Blood Donors
por: Nurmi, Visa, et al.
Publicado: (2023)

Convalescent plasma for COVID-19: male gender, older age and hospitalisation associated with high neutralising antibody levels, England, 22 April to 12 May 2020
por: Mehew, Jennifer, et al.
Publicado: (2020)

Rescue and in vitro characterization of a divergent TBEV-Eu strain from the Netherlands
por: Hoornweg, Tabitha E., et al.
Publicado: (2023)

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
por: Nguyen, Dung, et al.
Publicado: (2021)

First autochthonous human West Nile virus infections in the Netherlands, July to August 2020
por: Vlaskamp, Danique RM, et al.
Publicado: (2020)

Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)
por: Meyer, Benjamin, et al.
Publicado: (2020)

Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020
por: Harvala, Heli, et al.
Publicado: (2020)

Convalescent plasma donors show enhanced cross‐reactive neutralizing antibody response to antigenic variants of SARS‐CoV‐2 following immunization
por: Harvala, Heli, et al.
Publicado: (2022)

Changing to an Opt Out System for Organ Donation—Reflections From England and Netherlands
por: Jansen, N. E., et al.
Publicado: (2022)

Investigating Blood Donors With Postdonation Respiratory Tract Symptoms During the Wild-Type, Delta, and Omicron Waves of the Coronavirus Disease 2019 Pandemic in England
por: Gates, Shannah, et al.
Publicado: (2023)

Variability and pathogenicity of hepatitis E virus genotype 3 variants
por: Smith, Donald B., et al.
Publicado: (2015)

Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels
por: Harvala, Heli, et al.
Publicado: (2020)

Development of a Comparative European Orthohantavirus Microneutralization Assay With Multi- Species Validation and Evaluation in a Human Diagnostic Cohort
por: Hoornweg, Tabitha E., et al.
Publicado: (2020)

Comparison of Hepatitis E Virus Sequences from Humans and Swine, The Netherlands, 1998–2015
por: Hogema, Boris M., et al.
Publicado: (2021)

Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
por: Shankar-Hari, Manu, et al.
Publicado: (2020)

Donating convalescent plasma for COVID-19 patients
por: Black, Emily
Publicado: (2020)

Screening of post-mortem tissue donors for Coxiella burnetii infection after large outbreaks of Q fever in The Netherlands
por: van Wijk, Marja J, et al.
Publicado: (2014)

Fulminant Transfusion-Associated Hepatitis E Virus Infection Despite Screening, England, 2016–2020
por: Harvala, Heli, et al.
Publicado: (2022)

High prevalence of hepatitis B virus dual infection with genotypes A and G in HIV-1 infected men in Amsterdam, the Netherlands, during 2000-2011
por: van der Kuyl, Antoinette C, et al.
Publicado: (2013)

What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?
por: Focosi, Daniele, et al.
Publicado: (2021)

Treatment–donation-stockpile dynamics in ebola convalescent blood transfusion therapy
por: Huo, Xi, et al.
Publicado: (2016)

Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors
por: Vinkenoog, Marieke, et al.
Publicado: (2022)

Autochthonous dengue in two Dutch tourists visiting Département Var, southern France, July 2020
por: Vermeulen, Tom D, et al.
Publicado: (2020)

Convalescent plasma therapy for persistent hepatitis E virus infection
por: Ankcorn, Michael, et al.
Publicado: (2019)

Characterization of 100 sequential SARS‐CoV‐2 convalescent plasma donations
por: Jungbauer, Christof, et al.
Publicado: (2020)

Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved
por: Suzuki, Tetsuya, et al.
Publicado: (2023)

Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea
por: Delamou, Alexandre, et al.
Publicado: (2016)

Changes in transmission of Enterovirus D68 (EV-D68) in England inferred from seroprevalence data
por: Pons-Salort, Margarita, et al.
Publicado: (2023)

Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy
por: Gontu, Abhinay, et al.
Publicado: (2021)

A case of COVID-19 Convalescent Plasma Donation in Greece: Directed donation for compassionate use in the donor's critically ill father
por: Vlachogianni, Glykeria, et al.
Publicado: (2020)

Post mortem tissue donation in the Netherlands: a nationwide approach
por: van Leiden, H. A., et al.
Publicado: (2020)

Human Hantavirus Infections in the Netherlands
por: Sane, Jussi, et al.
Publicado: (2014)

Risk Factors and Screening for Trypanosoma cruzi Infection of Dutch Blood Donors
por: Slot, Ed, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h15c8n8hgc4ea2363dhvgagp3a